产品标题 产品货号 产品规格 厂家
REPS2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4177781 kitORIGENE TECHNOLOGIES
REPS1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4036111 kitORIGENE TECHNOLOGIES
Reps1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5146681 kitORIGENE TECHNOLOGIES
REPS2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31783010 ugORIGENE TECHNOLOGIES
Reps2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5146691 kitORIGENE TECHNOLOGIES
REPS2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31777810 ugORIGENE TECHNOLOGIES
Required for meiotic nuclear division 5 homolog A (S. cerevisiae) (RMND5A) from ORIGENE TECHNOLOGIESLY411569100 ugORIGENE TECHNOLOGIES
Required for meiotic nuclear division 5 homolog B (S. cerevisiae) (RMND5B) from ORIGENE TECHNOLOGIESLY411580100 ugORIGENE TECHNOLOGIES
RERE - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4144011 kitORIGENE TECHNOLOGIES
Rere - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5146711 kitORIGENE TECHNOLOGIES
RERG - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4035641 kitORIGENE TECHNOLOGIES
Rerg - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5146721 kitORIGENE TECHNOLOGIES
Human v-rel reticuloendotheliosis viral oncogene homolog A (avian) (RELA), transcript variant 1 from ORIGENE TECHNOLOGIESTP32078020 ugORIGENE TECHNOLOGIES
Human v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) (RALB) from ORIGENE TECHNOLOGIESTP30198220 ugORIGENE TECHNOLOGIES
Human v-rel reticuloendotheliosis viral oncogene homolog B (RELB) from ORIGENE TECHNOLOGIESTP30700620 ugORIGENE TECHNOLOGIES
Human V-set and immunoglobulin domain containing 2 (VSIG2) from ORIGENE TECHNOLOGIESTP72045310 ugORIGENE TECHNOLOGIES
Human V-set and immunoglobulin domain containing 2 (VSIG2) from ORIGENE TECHNOLOGIESTP30017020 ugORIGENE TECHNOLOGIES
Human V-set and immunoglobulin domain containing 8 (VSIG8) from ORIGENE TECHNOLOGIESTP31211820 ugORIGENE TECHNOLOGIES
Human V-set and immunoglobulin domain containing 4 (VSIG4), transcript variant 1 from ORIGENE TECHNOLOGIESTP30375120 ugORIGENE TECHNOLOGIES
Human V-set and immunoglobulin domain containing 4 (VSIG4), transcript variant 2 from ORIGENE TECHNOLOGIESTP72045410 ugORIGENE TECHNOLOGIES
Human V-set and immunoglobulin domain containing 4 (VSIG4), transcript variant 1 from ORIGENE TECHNOLOGIESTP72083710 ugORIGENE TECHNOLOGIES
Human V-set and transmembrane domain containing 2A (VSTM2A) from ORIGENE TECHNOLOGIESTP30619820 ugORIGENE TECHNOLOGIES
Human V-set and transmembrane domain containing 2A (VSTM2A) from ORIGENE TECHNOLOGIESTP72122710 ugORIGENE TECHNOLOGIES
Human V-set and transmembrane domain containing 2B (VSTM2B) from ORIGENE TECHNOLOGIESTP32821820 ugORIGENE TECHNOLOGIES
Human V-set and transmembrane domain containing 2 like (VSTM2L) from ORIGENE TECHNOLOGIESTP30765620 ugORIGENE TECHNOLOGIES
Human V-set and transmembrane domain containing 1 (VSTM1) from ORIGENE TECHNOLOGIESTP32461220 ugORIGENE TECHNOLOGIES
Human v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (SRC) from ORIGENE TECHNOLOGIESTP71001520 ugORIGENE TECHNOLOGIES
Human v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (SRC) from ORIGENE TECHNOLOGIESTP71002620 ugORIGENE TECHNOLOGIES
Human v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (SRC), transcript variant 1 from ORIGENE TECHNOLOGIESTP30862220 ugORIGENE TECHNOLOGIES
Human v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (SRC), transcript variant 2 from ORIGENE TECHNOLOGIESTP31185820 ugORIGENE TECHNOLOGIES
Human Vulva; Carcinoma in situ of vulva, squamous cell from ORIGENE TECHNOLOGIESCS5095555x5umORIGENE TECHNOLOGIES
Human Vulva; Carcinoma of vulva, squamous cell from ORIGENE TECHNOLOGIESCS7047125x5umORIGENE TECHNOLOGIES
Human Vulva; Carcinoma of vulva, squamous cell from ORIGENE TECHNOLOGIESCS8047585x5umORIGENE TECHNOLOGIES
Human Vulva; Carcinoma of vulva, squamous cell from ORIGENE TECHNOLOGIESCS8105155x5umORIGENE TECHNOLOGIES
Human Vulva; Carcinoma of vulva, squamous cell from ORIGENE TECHNOLOGIESCS8105165x5umORIGENE TECHNOLOGIES
Human Vulva; Carcinoma of vulva, squamous cell from ORIGENE TECHNOLOGIESCS8105175x5umORIGENE TECHNOLOGIES
Human Vulva; Carcinoma of vulva, squamous cell from ORIGENE TECHNOLOGIESCS5160885x5umORIGENE TECHNOLOGIES
Human Kidney; Nephritis, tubulointerstitial, chronic from ORIGENE TECHNOLOGIESCS6425145x5umORIGENE TECHNOLOGIES
Human Kidney; Nephritis, tubulointerstitial, chronic from ORIGENE TECHNOLOGIESCS6425155x5umORIGENE TECHNOLOGIES
Human Kidney; Nephroma, cystic, benign from ORIGENE TECHNOLOGIESCS7039255x5umORIGENE TECHNOLOGIES
Human Kidney; Nephroma, cystic, benign from ORIGENE TECHNOLOGIESCS5136765x5umORIGENE TECHNOLOGIES
Human Kidney; Nephroma, cystic, benign from ORIGENE TECHNOLOGIESCS5136745x5umORIGENE TECHNOLOGIES
Human Kidney; Nephropathy, diabetic from ORIGENE TECHNOLOGIESCS5101205x5umORIGENE TECHNOLOGIES
Human Kidney; Nephropathy, diabetic from ORIGENE TECHNOLOGIESCS5101215x5umORIGENE TECHNOLOGIES
Human Kidney; Nephropathy, diabetic from ORIGENE TECHNOLOGIESCS5101245x5umORIGENE TECHNOLOGIES
Human Kidney; Nephropathy, diabetic from ORIGENE TECHNOLOGIESCS5101255x5umORIGENE TECHNOLOGIES
Human Kidney; Nephrosclerosis from ORIGENE TECHNOLOGIESCS7018695x5umORIGENE TECHNOLOGIES
Human Kidney; Nephrosclerosis from ORIGENE TECHNOLOGIESCS6054345x5umORIGENE TECHNOLOGIES
Human Kidney; Nephrosclerosis from ORIGENE TECHNOLOGIESCS6234885x5umORIGENE TECHNOLOGIES
Human Kidney; Nephrosclerosis from ORIGENE TECHNOLOGIESCS6279815x5umORIGENE TECHNOLOGIES
 |< < 2233 2234 2235 2236 2237 2238 2239 2240 2241 > >| 第 2237/6274 页